Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas
Authors:
- Marta Araujo-CastroMarta Araujo-Castro
- Paola Parra RamírezPRPaola Parra Ramírez
- Cristina Robles LázaroCLCristina Robles Lázaro
- Rogelio García CentenoRCRogelio García Centeno
- Paola Gracia GimenoPGPaola Gracia Gimeno
- Mariana Tomé Fernández-LadredaMFMariana Tomé Fernández-Ladreda
- Miguel Antonio Sampedro NúñezMNMiguel Antonio Sampedro Núñez
- Mónica MarazuelaMónica Marazuela
- Héctor F. Escobar-MorrealeHEHéctor F. Escobar-Morreale
- Pablo ValderrabanoPVPablo Valderrabano
Open Access
- 25 November 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5509
Abstract
Purpose: To assess the risk of developing autonomous cortisol secretion (ACS) and tumour growth in non-functioning adrenal incidentalomas (NFAIs). Methods: Multicentre retrospective observational study of patients with NFAIs. ACS was defined as serum cortisol >1.8 µg/dL after 1 mg-dexamethasone suppression test (DST) without specific data on Cushing’s syndrome. Tumour growth was defined as an increase in maximum tumour diameter >20% from baseline; and of at least 5 mm. Results: Of 654 subjects with NFAIs included in the study, both tumour diameter and DST were re-evaluated during a follow-up longer than 12 months in 305 patients. After a median follow-up of 41.3 (IQR 24.7–63.1) months, 10.5% of NFAIs developed ACS. The risk for developing ACS was higher in patients with higher serum cortisol post-DST levels (HR 6.45 for each µg/dL, p = 0.001) at diagnosis. Significant tumour growth was observed in 5.2% of cases. The risk of tumour growth was higher in females (HR 10.7, p = 0.004). Conclusions: The frequency of re-evaluation with DST in NFAIs during the initial 5 years from diagnosis can probably be tailored to the serum cortisol post-DST level at presentation. Re-evaluation of NFAIs with imaging studies, on the other hand, seems unnecessary in most cases, particularly if the initial imaging demonstrates features specific to typical adenoma, given the low rate of significant tumour growth.Keywords
Funding Information
- Instituto Ramón y Cajal de Investigación Sanitaria (grant Convocatoria intramural de ayudas a proyectos de investigación de investigadores noveles, investigadores clínicos asociados y/o grupos emergentes del Hospital Universitario Ramón y Cajal 2019)
- Sociedad de Endocrinología, Nutrición y Diabetes de la Comunidad de Madrid (grant BECA SENDIMAD de Ayuda a la Investigación en Endocrinología, Nutrición y Diabetes 2019)
This publication has 31 references indexed in Scilit:
- Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional studyEuropean Journal of Endocrinology, 2012
- AME Position Statement on adrenal incidentalomaEuropean Journal of Endocrinology, 2011
- Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implicationsJournal of Internal Medicine, 2010
- American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: Executive Summary of RecommendationsEndocrine Practice, 2009
- [Adrenal incidentalomas: etiologic diagnostics and basic therapeutic management. A mini-review].2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Hormonal activity of adrenal incidentalomas: results from a long‐term follow‐up studyClinical Endocrinology, 2009
- Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter studyEuropean Journal of Endocrinology, 2009
- Prevalence of adrenal incidentaloma in a contemporary computerized tomography seriesJournal of Endocrinological Investigation, 2006
- Management of the Clinically Inapparent Adrenal Mass (Incidentaloma)Annals of Internal Medicine, 2003